February 27, 2015 12:06 PM ET


Company Overview of SymbioPharm GmbH

Company Overview

SymbioPharm GmbH develops microbial–pharmaceutical products. It offers Symbioflor 1, which is used for the treatment of recurring illnesses of the upper respiratory system; Symbioflor 2 that is used for the treatment of stomach-intestinal complaints for the children; Pro-Symbioflor, which trains the immune system; and SymbioLact that establishes vitamins, supports digestion, and assists the body’s own defense. The company also provides SymbioVag, a nutrient for the vaginal flora; SymbioFem plus, which contains Lactic acid bacteria and hormone-similar plant compounds from non-genetically modified soya; SymbioFem protect, a protective tampon impregnated with vaseline oil; and PolyZink, which c...

Auf den Lüppen

Herborn,  35745


Founded in 1954

Key Executives for SymbioPharm GmbH

SymbioPharm GmbH does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
OncoMab GmbH Europe
Migragen AG Europe
Central Glass Germany GmbH Europe
PET Net GmbH Europe
Micromet AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SymbioPharm GmbH, please visit www.symbiopharm.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.